يعرض 1 - 20 نتائج من 79 نتيجة بحث عن '"Indolent systemic mastocytosis"', وقت الاستعلام: 0.61s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal

    المصدر: Meditsinskiy sovet = Medical Council; № 15 (2024); 224–230 ; Медицинский Совет; № 15 (2024); 224–230 ; 2658-5790 ; 2079-701X

    وصف الملف: application/pdf

    Relation: https://www.med-sovet.pro/jour/article/view/8591/7546; Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200–1228. https://doi.org/10.1182/blood.2022015850.; Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022;36(7):1703–1719. https://doi.org/10.1038/s41375-022-01613-1.; Jackson CW, Pratt CM, Rupprecht CP, Pattanaik D, Krishnaswamy G. Mastocytosis and Mast Cell Activation Disorders: Clearing the Air. Int J Mol Sci. 2021;22(20):11270. https://doi.org/10.3390/ijms222011270.; Lange M, Hartmann K, Carter MC, Siebenhaar F, Alvarez-Twose I, Torrado I et al. Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021. Int J Mol Sci. 2021;22(5):2586. https://doi.org/10.3390/ijms22052586.; Касихина ЕИ, Потекаев НН, Иванова МА, Жукова ОВ, Новожилова ОЛ, Острецова МН, Окенаева А. Клинико-эпидемиологические характеристики кожного мастоцитоза среди детского населения города Москвы. Российский аллергологический журнал. 2024;21(1):74–81. https://doi.org/10.36691/RJA16906.; Vakirlis E, Theodosiou G, Apalla Z, Arabatzis M, Lazaridou E, Sotiriou E et al. A retrospective epidemiological study of skin diseases among pediatric population attending a tertiary dermatology referral center in Northern Greece. Clin Cosmet Investig Dermatol. 2017;10:99–104. https://doi.org/10.2147/CCID.S130126.; Касихина ЕИ, Потекаев НН, Кочетков МА, Жукова ОВ, Острецова МН, Медникова МА, Богдель АМ. Мастоцитоз: ретроспективный анализ пятнистопапулезной кожной формы. Медицинский совет. 2023;17(6):180–185. https://doi.org/10.21518/ms2022-005.; Rastogi V, Singh D, Mazza JJ, Parajuli D, Yale SH. Flushing Disorders Associated with Gastrointestinal Symptoms: Part 1, Neuroendocrine Tumors, Mast Cell Disorders and Hyperbasophila. Clin Med Res. 2018;16(1-2):16–28. https://doi.org/10.3121/cmr.2017.1379a.; Brockow K, Bent RK, Schneider S, Spies S, Kranen K, Hindelang B et al. Challenges in the Diagnosis of Cutaneous Mastocytosis. Diagnostics (Basel). 2024;14(2):161. https://doi.org/10.3390/diagnostics14020161.; Gilreath JA, Tchertanov L, Deininger MW. Novel approaches to treating advanced systemic mastocytosis. Clin Pharmacol. 2019;11:77–92. https://doi.org/10.2147/CPAA.S206615.; Hermine O, Lortholary O, Leventhal PS, Catteau A, Soppelsa F, Baude C et al. Case-control cohort study of patients’ perceptions of disability in mastocytosis. PLoS ONE. 2008;3(5):e2266. https://doi.org/10.1371/journal.pone.0002266.; Brockow K, Plata-Nazar K, Lange M, Nedoszytko B, Niedoszytko M, Valent P. Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis. Int J Mol Sci. 2021;22(5):2684. https://doi.org/10.3390/ijms22052684.; Barnes M, Van L, DeLong L, Lawley LP. Severity of cutaneous findings predict the presence of systemic symptoms in pediatric maculopapular cutaneous mastocytosis. Pediatr Dermatol. 2014;31(3):271–275. https://doi.org/10.1111/pde.12291.; Alvarez-Twose I, Vañó-Galván S, Sánchez-Muñoz L, Morgado JM, Matito A, Torrelo A et al. Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy. 2012;67(6):813–821. https://doi.org/10.1111/j.1398-9995.2012.02812.x.; Lange M, Niedoszytko M, Renke J, Gleń J, Nedoszytko B. Clinical aspects of paediatric mastocytosis: a review of 101 cases. J Eur Acad Dermatol Venereol. 2013;27(1):97–102. https://doi.org/10.1111/j.1468-3083.2011.04365.x.; Broesby-Olsen S, Carter M, Kjaer HF, Mortz CG, Møller MB, Kristensen TK et al. Pediatric Expression of Mast Cell Activation Disorders. Immunol Allergy Clin North Am. 2018;38(3):365–377. https://doi.org/10.1016/j.iac.2018.04.009.; Sandow L, Town A, Heinrich MC. Avapritinib treatment of aggressive systemic mastocytosis with a novel KIT exon 17 mutation. Leuk Res Rep. 2023;21:100409. https://doi.org/10.1016/j.lrr.2023.100409.; Caughey GH. Tryptase genetics and anaphylaxis. J Allergy Clin Immunol. 2006;117(6):1411–1114. https://doi.org/10.1016/j.jaci.2006.02.026.; Scudamore CL, Thornton EM, McMillan L, Newlands GF, Miller HR. Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum. J Exp Med. 1995;182(6):1871–1881. https://doi.org/10.1084/jem.182.6.1871.; Gülen T, Hägglund H, Dahlén B, Nilsson G. Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease. J Intern Med. 2016;279(3):211–228. https://doi.org/10.1111/joim.12410.; Parente R, Giudice V, Cardamone C, Serio B, Selleri C, Triggiani M. Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation. Int J Mol Sci. 2023;24(8):7071. https://doi.org/10.3390/ijms24087071.; Butterfield JH, Ravi A, Pongdee T. Mast Cell Mediators of Significance in Clinical Practice in Mastocytosis. Immunol Allergy Clin North Am. 2018;38(3):397–410. https://doi.org/10.1016/j.iac.2018.04.011.; Sperr WR, Stehberger B, Wimazal F, Baghestanian M, Schwartz LB, Kundi M et al. Serum tryptase measurements in patients with myelodysplastic syndromes. Leuk Lymphoma. 2002;43(5):1097–1105. https://doi.org/10.1080/10428190290021470.; Lieberman P, Nicklas RA, Randolph C, Oppenheimer J, Bernstein D, Bernstein J et al. Anaphylaxis-a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5):341–384. https://doi.org/10.1016/j.anai.2015.07.019.; van Anrooij B, Kluin-Nelemans JC, Safy M, Flokstra-de Blok BM, Oude Elberink JN. Patient-reported disease-specific quality-of-life and symptom severity in systemic mastocytosis. Allergy. 2016;71(11):1585–1593. https://doi.org/10.1111/all.12920.; Никитин СС, Гусева НБ, Карцева АА, Леухин МВ, Леписева ИВ. Современный взгляд на дифференциальную диагностику ультразвуковых характеристик лимфатических узлов при мезадените у детей. Медицинский совет. 2023;17(17):231–237. https://doi.org/10.21518/ms2023-269.

  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal

    المساهمون: Sciumè, Mariarita, Serpenti, Fabio, Zanotti, Roberta, Bonadonna, Patrizia, Tanasi, Ilaria, Crosera, Lara, Elena, Chiara, Mannelli, Francesco, Crupi, Francesca, Papayannidis, Cristina, Sartor, Chiara, Soverini, Simona, Rondoni, Michela, Eller‐Vainicher, Cristina, Pravettoni, Valerio, Rivolta, Federica, Alberti Violetti, Silvia, Croci, Giorgio Alberto, Migliorini, Anna Chiara, Bolli, Niccolò, Giannarelli, Diana, Grifoni, Federica Irene

    وصف الملف: ELETTRONICO

    Relation: volume:42; issue:3; firstpage:N/A; lastpage:N/A; numberofpages:4; journal:HEMATOLOGICAL ONCOLOGY; https://hdl.handle.net/11585/969236

  10. 10
  11. 11
  12. 12
    Academic Journal
  13. 13
    Academic Journal

    المصدر: Trizuljak , J , Sperr , W R , Nekvindova , L , Elberink , H O , Gleixner , K , Gorska , A , Lange , M , Hartmann , K , Illerhaus , A , Bonifacio , M , Perkins , C , Elena , C , Malcovati , L , Fortina , A B , Shoumariyeh , K , Jawhar , M , Zanotti , R , Bonadonna , P , Caroppo , F , Zink , A , Triggiani , M , Parente , R , von Bubnoff , N , Yavuz , A ....

    وصف الملف: application/pdf

  14. 14
  15. 15
    Academic Journal
  16. 16
  17. 17
  18. 18
    Academic Journal
  19. 19
    Academic Journal

    المساهمون: Department of Dermatology, Allergology and Venereology, Clinicum

    وصف الملف: application/pdf

    Relation: Broesby-Olsen , S , Dybedal , I , Gulen , T , Kristensen , T K , Moller , M B , Ackermann , L , Saaf , M , Karlsson , M , Agertoft , L , Brixen , K , Hermann , P , Stylianou , E , Mortz , C G , Torfing , T , Havelund , T , Sander , B , Bergstrom , A , Bendix , M , Garvey , L H , Weis Bjerrum , O , Valent , P , Bindslev-Jensen , C , Nilsson , G , Vestergaard , H & Hagglund , H 2016 , ' Multidisciplinary Management of Mastocytosis : Nordic Expert Group Consensus ' , Acta Dermato-Venereologica , vol. 96 , no. 5 , pp. 602-+ . https://doi.org/10.2340/00015555-2325; http://hdl.handle.net/10138/164962; 93dd51f7-7b1e-42b6-a818-0dbadaca6410; 84973597978; 000378883900004

  20. 20

    المصدر: Journal of Allergy and Clinical Immunology, 146(2), 300-306. MOSBY-ELSEVIER
    The Journal of Allergy and Clinical Immunology
    Valent, P, Akin, C, Bonadonna, P, Brockow, K, Niedoszytko, M, Nedoszytko, B, Butterfield, J H, Alvarez-Twose, I, Sotlar, K, Schwaab, J, Jawhar, M, Reiter, A, Castells, M, Sperr, W R, Kluin-Nelemans, H C, Hermine, O, Gotlib, J, Zanotti, R, Broesby-Olsen, S, Horny, H P, Triggiani, M, Siebenhaar, F, Orfao, A, Metcalfe, D D, Arock, M & Hartmann, K 2020, ' Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic : Expert opinions ', Journal of Allergy and Clinical Immunology, vol. 146, no. 2, pp. 300-306 . https://doi.org/10.1016/j.jaci.2020.06.009
    Journal of Allergy and Clinical Immunology

    مصطلحات موضوعية: 0301 basic medicine, MIDOSTAURIN, coronavirus, COVID-19, KIT D816V, mast cell activation syndrome, Mast cells, mastocytosis, SARS-CoV-2, tryptase, Betacoronavirus, Comorbidity, Coronavirus Infections, Diphosphonates, Expert Testimony, Glucocorticoids, Histamine Antagonists, Humans, Immunosuppressive Agents, Mast Cells, Mastocytosis, Cutaneous, Mastocytosis, Systemic, Myeloablative Agonists, Pneumonia, Viral, Precision Medicine, Risk Factors, Vitamin D, Disease Management, Pandemics, medicine.medical_treatment, Hematopoietic stem cell transplantation, Disease, medicine.disease_cause, MCA, Mast cell activation, 0302 clinical medicine, Pandemic, INFECTION, Immunology and Allergy, CRITERIA, Viral, 030212 general & internal medicine, Systemic mastocytosis, MCAS, Mast cell activation syndrome, Coronavirus, BM, Bone marrow, CM, Cutaneous mastocytosis, SAFETY, MAST-CELLS, medicine.symptom, CELL ACTIVATION SYNDROMES, medicine.medical_specialty, DISORDERS, Immunology, Mast cell activation syndrome, DIAGNOSIS, Article, WHO, World Health Organization, CLASSIFICATION, KITD816V, 03 medical and health sciences, medicine, Intensive care medicine, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2, Corona Virus, business.industry, Cutaneous Mastocytosis, Systemic, Pneumonia, medicine.disease, EFFICACY, Cutaneous, 030104 developmental biology, IgE, Immunoglobulin E, MC, Mast cells, SM, Systemic mastocytosis, COVID-19, Corona virus disease 2019, business, ISM, Indolent systemic mastocytosis

    وصف الملف: application/pdf